Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Betamethasone | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 2 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
|
| 2 | BETAMETHASONE ACIBUTATE | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 3 | Betamethasone mouthwash | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 56 56 💬
|
| 4 | Betamethasone Oral Solution Period 1 and Period 2 | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 5 | Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days | [2] Acetate Acetate,Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
| 6 | Betamethasone solution as intramuscular injection Period 1 and Period 2 | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 7 | Intra-articular Compound Betamethasone | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 8 | Intraarticular betamethasone | [1] Betamethasone Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 9 | Phosphate and betamethasone acetate, 2 mL. | [2] Acetate Acetate,Betamethasone (Betamethasone sodium phosphate) | [6] Betamethasone
Betamethasone
(Betamethasone),Betamethasone sodium phosphate (Betamethasone sodium phosphate), Betamethasone valerate (Betamethasone valerate), Betamethasone acetate (Betamethasone acetate), Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%), Betamethasone benzoate (Betamethasone benzoate) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 235 235 💬
|
